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Abstract The recent advancements in the field of laser-
driven particle acceleration have made Laser-driven Ion
Beam Therapy (L-IBT) an attractive alternative to the
conventional particle therapy facilities. To bring this
emerging technology to clinical application, we introduce
the broad energy assorted depth dose deposition model
which makes efficient use of the large energy spread and
high dose-per-pulse of Laser Accelerated Protons (LAP)
and is capable of delivering homogeneous doses to tumors.
Furthermore, as a key component of L-IBT solution, we
present a compact iso-centric gantry design with 360
rotation capability and an integrated shot-to-shot energy
selection system for efficient transport of LAP with large
energy spread to the patient. We show that gantry size
could be reduced by a factor of 2–3 compared to conven-
tional gantry systems by utilizing pulsed air-core magnets.
1 Introduction
Radiation therapy plays a major role in cancer treatment by
not only providing local tumor control, but also a cost-
effective way to improve quality of life of late stage cancer
patients. In developed countries, more than 50 % of all
cancer patients undergo radiation therapy during the course
of their treatment while the total number of patients is
increasing every year. Currently, compact medical linear
accelerators, producing photon and electron beams with
energies up to 20 MeV, are the most common way to
deliver radiation doses to tumor volumes. The accelerator
and the components for beam delivery and formation are
mounted on an iso-centric gantry with 360 rotation angle.
This allows a flexible choice of irradiation field direction
according to clinical requirements for individual patients,
i.e., irradiating the tumor while sparing critical organs in
the beam path. However, due to the characteristic depth
dose profile of photons and electrons (maximum dose close
to the entrance and subsequently decreasing dose with
increasing penetration depth) it is difficult to prevent
damaging healthy tissues around deep seated tumors. The
use of charged particle beams (protons or heavier ions)
may provide superior dose conformity in tumor volumes
while better sparing normal tissues and organs at risk [1, 2]
since they deliver low dose at entrance and maximum dose
near the end of their range [3, 4] (see Fig. 1). Currently,
radiation therapy, by photons and electrons, provides
*60 % treatment success. However, it is estimated that at
least 10–20 % of all radiotherapy patients may benefit from
Ion Beam Therapy (IBT) [5, 6].
In IBT, large conventional accelerators (cyclotrons or
synchrotrons) are deployed to produce particle beams with
high energies (e.g., 70–250 MeV protons), which are
necessary to deliver doses at clinically relevant depths (of
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up to 30 cm). These beams are then transported via mag-
netic transfer lines to several treatment rooms and deliv-
ered to patients preferably via a 360 rotatable gantry
system. However, at these high energies, particle beams
become highly rigid and beam transport by conventional
iron-core magnets require big and heavy transfer lines and
beam gantries. Existing IBT iso-centric gantries therefore
are massive and large (e.g., for protons: above 100 tons,
*7–11 m diameter and *9–12 m in length) and must be
supported by enormous and massive architectural com-
plexes and support structures which house and rotate the
whole gantry systems around the patient table with high
precision. This all adds up to the complexity and cost of
IBT facilities [7] with capital investments easily exceeding
100 million Euros. This is the main reason for limiting IBT
implementation to few large centers and hindering the wide
spread of particle therapy around the world.
In order to reduce the size and cost of IBT systems,
several novel technologies are under investigation such as
high field superconducting synchrocyclotron systems,
which even may be mounted onto a rotating gantry [8],
combination of cyclotron and linear accelerators [9], non-
scaling fixed-field alternative gradient accelerator concepts
[10, 11], dielectric-wall accelerators [12] and laser particle
acceleration mechanisms [13–17]. However, recent huge
advancements in the field of laser-driven particle acceler-
ation have made Laser-driven Ion Beam Therapy (L-IBT) a
very promising and attractive alternative to conventional
IBT (con-IBT) facilities [15–18]. By replacing conven-
tional accelerators with table top high power laser systems
may considerably reduce the size and cost of IBT facilities.
Moreover, laser pulses can be guided to target assemblies
inside several treatment rooms by compact optical lines
with mirrors making heavy magnetic transfer lines obso-
lete. Nonetheless, apart from actual accelerator and trans-
fer-lines, the size of the gantry is still a limiting factor and
the size and cost reduction of IBT facilities through laser-
driven accelerators can only be capitalized on if the size
and weight of the associated gantry systems can be
reduced.
The properties of laser-driven beams, e.g., ultra-intense
particle bunches with large energy spread and divergence,
are different from conventional beams. Therefore, new
methods and techniques for beam transport, irradiation
field formation and treatment planning [19–21], along with
beam-monitoring, dosimetry and dose-controlled irradia-
tion [22–26] are required. Moreover, determination of
radio-biological effects induced by ultrashort intense par-
ticle bunches [26–32] is necessary. In addition to laser
particle accelerator development, a parallel oncology-
focused research and development is essential to bring this
highly promising technology to the clinics.
In this paper we present a depth dose deposition model
optimized for L-IBT and an energy-selective compact 360
iso-centric gantry design with efficient capturing of diver-
gent bunches and integrated energy filtering system. The
pulsed nature of the laser accelerated ion beam generation
has allowed us to utilize air-core high field pulsed magnet
systems over iron-core magnets for our gantry design.
Pulsed magnets can achieve higher magnetic field strengths
at a comparatively smaller size, but a beamline system
consisting of pulsed magnets has never been deployed
before. Our proposed design for laser-driven beams results
in a substantial reduction in size by a factor of 2–3, and
hence weight, compared to the most compact con-IBT
gantry systems for coasting beams.
Fig. 1 a Single-field-uniform-dose scheme; the depth dose profiles
(green) are shown as a function of penetration depth in water,
displaying a pristine Bragg peak corresponding to a proton beam with
energy spread of *1–3 %. A flat-top SOBP (red) is achieved by non-
linear superposition of these energy- and intensity-modulated Bragg
peaks. The SOBP has an acceptable ±3–5 % dose uniformity within
the tumor region bounded by the proximal (near) and distal (far)
edges of tumor region, depending upon the beam entrance. More
complex depth dose regimes than single-field-uniform-dose are also
commonly practiced with beams entering from two or more
directions; b shows two SOBPs (dashed blue) matched in the middle
of the tumor region, while c shows overlapped SOBPs (dashed blue).
The first variant cover larger extent of tumor widths and can also be
achieved by matching slanting SOBPs, and the latter variant delivers
a higher peak to entrance dose ratio. In con-IBT, a combination of
these schemes is used for patient treatment plans with higher order of
complexity to optimize tumor conformity and normal tissue sparing
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2 Laser particle accelerator
In laser-driven ion acceleration, a highly focused ultra-
intense laser pulse (with peak light intensity of
1019 W cm-2 or higher) interacts with thin (*lm) solid
density targets. The most commonly used and best under-
stood mechanism to accelerate ion beams by lasers is
Target Normal Sheath Acceleration (TNSA) [13, 33]. In
this robust acceleration mechanism, first the light field
generates a plasma plume in the laser focal region. The
electrons in the plasma are accelerated by the laser field,
pass through the target and exit it at the rear side. These
electrons form a negatively charged sheath that extends up
to the Debye length (lm to nm scale depending on laser
and target parameters) which generates a quasi-static
acceleration field for positively charged ions on the target
rear side which is of the order of TV/m. The accelerated
ion bunches are pulsed and have an exponential energy
spectrum and large energy-dependent divergence angles,
with an upper limit for repetition frequency coming from
the high power laser systems which extends from 10 Hz for
ultrashort pulse durations (\50 fs) to few pulses per minute
for long pulse (*700 fs) laser systems. Although, several
ion species can be accelerated through laser-matter inter-
actions, we focus our work on Laser Accelerated Protons
(LAP) since protons are much more often used than heavier
ions in con-IBT [34]. The maximum proton energies cur-
rently published could reach up to *70 MeV [35] by a
long pulsed laser system of few 100 Terawatt power and
are not yet sufficient for most radiation therapy purposes.
However, scaling models show higher energies are reach-
able with increased laser power [36–38] and/or new target
geometries [39]. Also, several laser particle acceleration
mechanisms are under investigation which could be more
efficient yet experimentally much more demanding than
TNSA, such as laser-piston regime [40], radiation pressure
acceleration [41, 42] and breakout afterburner regime [43,
44], which could provide higher-energy ion beams with
potentially better beam quality (i.e., lower-energy spread
with better collimation). Nevertheless, with the develop-
ment of next generation Petawatt (1,000 Terawatt) laser
systems, protons with much higher energies are expected to
be reached in the near future. However, in this paper we
have used a scaled TNSA spectrum for input parameters as
worst case scenario to design the beamline.
Laser-driven ion beam therapy will be different from
con-IBT in several ways [45]. For instance, due to the
pulsed nature of high power laser systems, with low rep-
etition rates of a few laser pulses per second, the acceler-
ated proton bunches are also pulsed with bunch durations
of nsec range and with up to *1012 protons per bunch
depending upon laser parameters [28, 46]. Such intense
bunches can attain pulsed peak dose rate values up to
1010 Gy/s which exceeds con-IBT mean values of
15–30 Gy/s through quasi-continuous beam by many
orders of magnitude. Therefore, L-IBT poses a whole new
set of challenges on both physical and biological levels.
Laser-driven irradiation technology with all the necessary
main components (such as high power laser system and
laser target to produce the particle beam, and also beam
transport and monitoring as well as dose delivery tech-
nique) has already been developed to perform in-vitro cell
[26–32] and small animal [24, 26] irradiation with low
energy LAP within radiobiological experiments. These
recent promising results encourage a go-ahead with further
L-IBT solutions.
3 Laser-driven versus conventional IBT dose delivery
In most sophisticated con-IBT, pencil-like monoenergetic
beams with energy spread of DE=E *1–3 % with
decreasing energy and intensity are superimposed to deli-
ver uniform doses to the tumor region via a spread out
Bragg peak (SOBP) (Fig. 1) [4, 47]. Nevertheless, a clin-
ically relevant SOBP of certain width and at certain depth
requires a broad energy window to scan the complete depth
of the tumor. The inherent laser acceleration process sug-
gests LAP beams with therapeutic energies would be far
from monoenergetic, but with high bunch intensities (par-
ticle number) and large divergences. As a consequence, the
broad energy spectrum may already contain the required
energy windows for SOBPs with sufficient amounts of
protons to deliver enough dose for treatment purposes over
a short time, i.e., by reasonable low number of bunches.
However, capturing divergent protons and efficient energy
selection system is necessary for any L-IBT solution.
Uniform doses in clinical settings with LAP bunches can
be delivered either by filtering out quasi-monoenergetic
(DE=E *5–10 %) protons from a predicted therapeutic
broad LAP spectrum and superimpose multiple filtered
bunches akin to con-IBT [19, 48] or to achieve a SOBP by
a single filtered broad energy bunch in combination with
shaping the energy spectrum by physical wedges [49].
Such proposed schemes were based on a compact beamline
with a primary collimator in front of a magnetic chicane
filter [19, 48]. Due to the very small opening angle (0.6) of
the primary collimator, used to limit diverging LAP bun-
ches, such beamline uses a mere of *0.02 % of all protons
in a bunch for dose delivery [50], while depositing huge
numbers of protons in beam dumps and producing a high
level of secondary (background) radiations. Such collima-
tor-based beamlines are highly inefficient [51] reducing the
per bunch dose. The advanced treatment planning tech-
nique optimized for LAP beams proposed by Schell [20]
and Hofmann [21] could be a good way to go, but the
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presented method of dose delivery is, however, based on
the before mentioned collimator-based beamline.
For L-IBT to be competitive with con-IBT, any successful
scheme must make efficient use of the high number of pro-
tons available in each LAP bunch, as repetition rates of high
power lasers are limited to few pulses per second. The
demand on short treatment times of below 10 min thus
requires the clinically relevant total dose to be delivered by
not more than a few thousand bunches. Spatial and energy-
dependent filtering must therefore be optimized for
throughput to keep proton numbers high. As this up to now
requires to capture and transport strongly divergent pulsed
proton bunches of broad energy spread, both the method to
deposit a homogeneous dose distribution in the tumor vol-
ume and the gantry design have to reflect these constraints.
4 Scaling of existing data
Currently, there is no experimental data available for LAP
in the full therapeutic energy range which could be used as
realistic input parameters for our depth dose deposition
model and beamline design. However, for this study, we
have exploited and scaled available data from the Dresden
laser acceleration source (DRACO), which is a 10 Hz
150 TW ultrashort (*30 fs) pulsed laser system [52]. We
have averaged proton energy spectra of five bunches
(shown in Fig. 2a as green line) and then scaled it to the
energy range required for therapy, using a similar approach
presented in ref. [46]. An exponential fit to the averaged
data is made, which can be described by:
dN=dE ¼ N0eE=E0 ð1Þ
where N0 = 2 9 10
11 MeV-1 and E0 = 2.33 MeV (shown
in Fig. 2a as yellow dashed line). For scaling this spectrum
to therapeutic energy range both proton energies
E observed in experiments and the characteristic slope
parameter are increased by a factor of 250/14 = 17.86
while conserving the total number of protons available for
acceleration. Thus after scaling N0 drops to 1 9 10
10
MeV-1 with E0 = 46.73 MeV, yielding a scaled function
for higher energies, shown in Fig. 2a as red dashed
line. Laser-driven proton sources exhibit energy-depen-
dent large divergences, which decreases with increasing
proton energies within a bunch. For realistic scaling, this
angular dependence of LAP spectra has to be accounted
for. The half-angle divergences observed in experiments
can be defined by a power fit as:
hðEÞ ¼ aEk ð2Þ
with a = 19.48 and k = -0.15. We have extrapolated
Eq. 2 to 250 MeV, showed as dashed cyan line in Fig. 2b.
To provide a safety margin on beamline parameters, we
have added a constant of 2 to this fit to compensate any
fluctuations or deviation that might occur in future exper-
iments, which is a very conservative approach as diver-
gences of LAP beams are expected to decrease for higher
energies. The scaled angular energy dependence can now
be defined by Eq. 2 with a = 20.98 and k = -0.13, which
is shown in Fig. 2b as blue line. These scaled functions, in
Fig. 2a, b, were then used to generate LAP bunches for
simulation inputs by a Monte Carlo code.
5 Broad energy assorted depth dose deposition model
In our dose model, SOBPs are realized by the superposition
of depth dose profiles of individual LAP bunches with
varied energy bandwidths. In the following, this technique
is referred to as Broad Energy Assorted depth Dose
Fig. 2 a Shows an averaged energy spectrum is shown as green-line
(top energy axis) measured at the DRACO laser system with an
exponential fit shown as dashed yellow-line (top energy axis). The
scaled function predicts a proton spectrum over therapeutic range and
is shown as dashed red-line (bottom energy axis), while the blue-line
shows the spectrum (bottom energy axis) of a proton bunch generated
through Monte Carlo code. b Shows the energy-dependent half-angle
divergence observed in experiments (shown as solid cyan-line),
extrapolated to therapeutic energies (shown as dashed cyan-line) and
with an added constant of 2 for the safety margin (shown as blue-
line)
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deposition (BEAD). As one laser pulse is required on the
target to generate one LAP bunch, we call it as one shot. In
order to understand BEAD, let us consider a tumor to be
irradiated (see Fig. 3). The energy windows selected to
create a SOBP within the tumor region must lie within the
energy range set by the minimum energy Emin corre-
sponding to the depth of the proximal edge of the tumor
and the maximum energy Emax corresponding to the depth
of the distal edge. The energy window thus defined by
DE ¼ Emax  Emin, with centered nominal energy of
En = (Emax ? Emin)/2, can be referred as ‘‘useful energy
window’’ within the initial spectrum. If this DE=En band
could be filtered out, its depth dose profile is neither a flat-
top SOBP nor a pristine Bragg peak, but displays a peak
and bounded plateau situated within the tumor region (see
Fig. 3b). In the following, we conservatively assume that a
single shot does not deliver the clinically relevant dose of
2 Gy to the tumor, and for the purpose, multiple shots
could be superimposed.
Figure 4 is a schematic representation of a single-field-
uniform-dose regime with our BEAD model by superim-
posing several individually filtered LAP shots. The first LAP
shot (shot1) was filtered with DEshot1=Enðshot1Þ ¼ 21:4%,
required to produce a baseline dose profile covering the
entire tumor depth. The second LAP shot (shot2) was
delivered with a narrowed energy window, DEshot2, as
compared to shot1 while increasing nominal energy as
Enðshot2Þ ! Emax to fill the shallow dose region toward the
distal edge. This implies Emin for the next consecutive
shots to be greater than the previous shot, such as
Emin(shot1) \ Emin(shot2) \ Emin(shot3)_\ Emin(shot-last). The
shot2 with DEshot2=Enðshot2Þ ¼ 18:5% was superimposed on
shot1. Due to the exponentially decreasing energy spectrum,
shots with En ! Emax and smaller DE windows contain
lesser number of protons thus multiple deposition of shots
would be needed to flatten the cumulative dose profile. For
this reason, shot3 with DEshot3=Enðshot3Þ ¼ 8:60% and shot4
with DEshot4=Enðshot4Þ ¼ 6:0% were deposited twice. The
last shot (shot5) was deposited eight times, because of rela-
tively smaller DEshot5=Enðshot5Þ of 3.60 % containing lesser
particles, to achieve a flat-top SOBP.
The flatness (or dose homogeneity) of the resultant
SOBP could be enhanced by decreasing the difference in
the energy windows between two consecutive shots
DEn21 ¼ Enðshot2Þ  Enðshot1Þ, while the total number of
shots, NLAP required would also increase, which would
directly translate into longer treatment times. Thus, for a
specific treatment plan, there is a trade-off between
required flatness and treatment time. In our example,
NLAP = 14 were needed for a normalized SOBP within an
acceptable uniformity of ±4 %, using five different DE=En
settings. We found DE=En ¼ 22 3% bands were suffi-
cient to produce a normalized SOBP of *5 cm width at
depths of 5–25 cm. The NLAP required to scan the complete
depth of the tumor for a prescribed dose depends on three
sets of factors:
1. LAP bunch properties, such as characteristic slope of
the spectrum, divergence angles and total number of
protons per energy range.
2. Tumor aspects, such as width, depth and required
uniformity in delivered dose.
3. Beamline (gantry) parameters, such as energy accep-
tance, capture and transport efficiencies per energy range.
Fig. 3 a Shows TNSA like scaled exponential function for energy
spectrum of laser accelerated protons. The top horizontal axis
displays the range in water for protons with corresponding energies
given on the bottom axis. The tumor position is marked by a red bar,
while the ‘‘useful energy window’’ corresponding to the tumor range
is hatched in blue. b Shows a comparison between depth dose profiles
of two LAP shots with (1) a broad energy band of DE=E0  22 %
corresponding to the ‘‘useful energy window‘‘ in (a), and (2) a narrow
energy band of DE=E0  1:3 % similar to single Bragg peaks used in
con-IBT
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The first set could be considered predetermined due to
the features of laser particle accelerators, while the second
set could be considered fixed due to the clinical require-
ments. While we have focused on the third set and aimed to
design a compact beamline (gantry) capable of capturing,
filtering and transporting desired DE=En ranging from 22 to
3 % bands at any required En, with maximum possible
transport efficiency g(En).
6 Gantry design
The magnetic rigidity (Bq), described as Bq = momentum/
charge, states that higher magnetic field strength B is
required for higher-energy protons to follow a compact
bending radius q which in turn determines the size of any
gantry in question. The maximum magnetic field strength
Bmax achievable by conventional resistive magnets is lim-
ited by saturation of the magnetization of the iron-core to a
value of Bmax *1.9 T. However, pulsed magnets are air-
core designs powered by pulsed energy supplied by
capacitor banks (for more see ref.[53]). By eliminating the
core saturation issue, Bmax achievable with pulsed magnets
is mainly limited by the peak current provided by the
power supply and by the mechanical strength of the con-
struction materials needed to hold intense magnetic pres-
sures. A 90 bending conventional iron-core magnet limits
q to *1.13 m for 200 MeV protons, but if pulsed magnets
could be constructed with field strengths of Bmax *8 T, it
could be possible to reduce q down to *0.27 m.
The pulsed nature of laser systems and hence the pulsed
LAP bunches allowed us to consider pulsed magnets for
Fig. 4 Shows the flat-top SOBP
(red) as it evolves due to
superimposing energy-filtered
individual LAP shots (blue), see
text for the detailed description
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our gantry design. Due to the higher magnetic fields
achievable by pulsed magnets, we were able to reduce the
size of our gantry to 1.7 m in radius and *3.0 m in length
which is about two times smaller in height and about three
times shorter in length than compact conventional iso-
centric gantries being deployed in con-IBT facilities. Also,
due to the missing iron-core, pulsed magnets are much
lighter in weight than conventional magnets.
The magnetic fields in pulsed magnets usually have a
rise time in the range of few 100 ls with pulse durations of
the order of ms, thus fields can be considered constant
during ns LAP bunches traversing through them. Pulsed
solenoids have already been successfully deployed to
capture and collimate LAP bunches in experiments [46,
54]. These studies demonstrate a good control over the
magnetic-field-pulsing mechanism synchronized with laser
pulses. With currently achievable proton energies, such
experiments required only low magnetic field values;
however, realizing higher field strengths is possible
through present day technologies.
Our concept L-IBT solution is comprised of a laser
source outside the treatment room, capable to channel laser
pulses into several rooms. A laser-target assembly is con-
sidered to be mounted inside a 360 rotatable iso-centric
gantry. Laser pulses enter the gantry along the axis through
the iso-center and are deflected into the laser-target
chamber, where laser interacts with target to generate
accelerated proton bunches perpendicular to the patient
table (see Fig. 5 for the complete setup). All magnets
considered are air-core designs powered by a system
capable to pulse each magnet at 10 Hz synchronized with
the laser pulses, which would provide a full control over
the magnetic field strengths in individual magnets of the
beamline for each LAP bunch traversing through them
A pulsed power solenoid, with aperture radius of
2.75 cm is used to couple laser-target assembly and
beamline. The solenoid acts as an axially symmetric
chromatic focusing lens and efficiently captures divergent
protons to make a well-defined beam (for details see [46,
51, 54–56]). Its field strength can be selectable
(0 \ Bo \ 40 T) for each bunch so that protons with one
optimized energy Eopt are collimated, while protons with
E  Eopt experience a much lower force inside the sole-
noid and continue to diverge while protons with E  Eopt
experience a much greater force and diverge after focusing
strongly, which also provide a coarse first-step energy
selection. The beam is collimated around Eopt so that to
match it to the following dipole bending magnet.
A fine energy filtering system has been devised and
incorporated in our gantry design. This Integrated Shot-to-
shot Energy Selection System (ISESS) is based on a 90
bending sector magnet SM1 and a quadrupole triplet QT1
with two physical apertures. Energy dispersion in SM1
allows energy selection as a function of magnetic field
BSM1. The beam diameter at this point is large due to the
aperture size of the solenoid which was necessary for
maximum capture efficiency; therefore, fine energy selec-
tion is not possible with SM1 only. For fine-tuned
Fig. 5 Schematic
representation of 360 iso-
centric gantry concept for
particle therapy with LAP,
including a radiation protection
cave housed around the patient
table. A Monte Carlo generated
LAP bunch with energy
spectrum shown in Fig. 2a was
tracked through our double-
achromatic beamline design, as
shown by the color spread
inside the picture and described
by the colored energy scale. The
beamline elements are drawn on
the tracks to illustrate their
positions, with working
parameters listed at the bottom.
A water phantom underneath
the exit window represents the
setup used for the depth dose
simulations in Geant4
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selection, a pulsed quadrupole triplet (QT1) follows SM1
which acts as a strong chromatic focusing lens. The mag-
netic gradients are tuned to focus protons with Eopt at
15 cm after QT1. Aperture A2 with fine variable opening
radius RA2 is placed to effectively filter protons around Eopt
with the bandwidth DE=Eopt, where the bandwidth directly
depends on RA2. A second quadrupole triplet (QT2) after
A2 recaptures the filtered bunch, and the second 90
bending sector magnet (SM2) bends the beam toward the
patient table. This magnetic arrangement allows for can-
celing the dispersion introduced earlier for energy selection
in the SM1 to zero, hence achieving a doubly achromatic
transport beam line. A third quadrupole triplet QT3, fol-
lowed by conventional physical collimators, is introduced
after SM2 which in principle could be used to re-shape the
filtered bunch to desired field sizes of 1–6 cm in diameter
at iso-center. The patient table is considered to be enclosed
by a radiation protection cave. The patient table can be
moved precisely to scan the beam across the tumor volume
to apply multiple laterally adjacent fields to homogenize
dose over larger volumes.
7 Particle transport through the gantry design
The scaled spectrum and angular dependence functions
(Fig. 2, explained in Sect. 4) have been used to generate
LAP bunches for the particle tracking simulations via a
Monte Carlo code. These Monte Carlo LAP bunches were
then transported through the gantry setup in general parti-
cle tracer (GPT) version 3.0 code [57]. Two sets of simu-
lations have been performed. In the first set, the capability
of the ISESS to filter DE=Eopt bandwidths is investigated as
the radius RA2 of aperture A2 was varied from 12 to 1 mm.
The magnetic field values in each of the magnets were
optimized for a single Eopt. Figure 6a shows the simulation
results with Eopt set to 148 MeV by fixing optimized
magnetic field values in each magnetic element. ISESS was
able to filter a bell-shaped spectrum out of the input bunch
spectrum with a peak at the selected Eopt, while the bunch
was transported through the beamline from laser-target
chamber to the patient table with high efficiency. The fil-
tered bandwidth DE=Eopt decreased from 25 % at
RA2 = 12.0 mm to 4.1 % at RA2 = 2.0 mm with almost
constant transport efficiency of g(Eopt) & 22 %. However,
below RA2 = 2.0 mm g(Eopt) dropped quickly, due to
chromatic aberrations, to 5 % for DE=Eopt ¼ 1:4% at
RA2 = 1.0 mm. Nevertheless, a satisfactory control over
DE=Eopt as function of RA2 was established over the desired
bandwidth range of 3–22 %.
The second set of simulations was performed to estab-
lish a control to select desired value of Eopt [MeV] at the
exit window. Normally, 1–1.5 mm range steps are used in
con-IBT to scan the complete depth of the tumor which
would require *0.5 MeV controllable energy steps. This
translates to a requirement of a controllable step change in
magnetic field values in each magnet with an accuracy of
10-2 T, which is achievable with present day technology
and thus assumed as incremental change in Eopt. One
Monte Carlo generated LAP bunch was transported for
fixed RA2 aperture size with B fields optimized for Eopt_1,
while for a second consecutive LAP bunch, B field
strengths were reduced such that now protons with Eopt_2
(\Eopt_1) would be transported. Figure 6b shows the results
of five simulations with RA2 = 3.0 mm for transporting
LAP bunches with Eopt optimized for five different values,
shown in the figure.
These two sets of simulation results established the
control over the whole spectrum for selecting any desired
energy window per pulse, thus showing the capability and
functionality of the presented compact gantry design to
implement the BEAD scheme.
Fig. 6 A Monte Carlo generated LAP bunch with scaled energy
spectrum (blue) was transported through the gantry in GPT simula-
tions. a Shows results with ISESS set to deliver Eopt = 148 MeV with
five RA2 settings were used for five consecutive LAP bunches. The
filtered DE=Eopt width at the exit window for each Rapt setting is
shown, while b shows the filtered spectrum through ISESS at fixed
RA2 = 3.0 mm while Eopt values are varied through selecting
optimized magnetic field strengths for each magnetic element of the
beamline
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8 BEAD through the gantry design
Depth dose profiles of individually filtered LAP bunches
and superimposed dose distributions from multiple filtered
shots were simulated in a 10 9 10 9 30 cm3 water phan-
tom using the Geant4 simulation code [58]. Particle posi-
tions and velocities at the exit window of the gantry from
GPT simulations were taken as input to the Geant4 simu-
lations. We were able to reproduce the SOBP shown in the
BEAD (single-field-uniform-dose) example in Fig. 4. The
SOBP was achieved by superimposing multiple LAP shots
with five different optimized beamline settings of DE=Eopt
for Eopt = En as given in the initial example. The simulated
depth dose profiles in the water phantom are shown in
Fig. 7a. It took NLAP = 19 shots to reach a normalized
SOBP, within uniformity of ±3 %. This is more than the
expected 14 shots as discussed in Sect. 5, and this slight
increase in shot number is due to the change in spectral
shape of filtered shots.
To deliver a clinically relevant uniform dose of 2 Gy, to
a water equivalent tumor volume of 1 l, the normalized
scheme mentioned above is needed to be implemented
multiple times. For this, we have roughly estimated that
*600 laser-shots would be required, provided a laser-dri-
ven proton source with a pulse-to-pulse dose fluctuation of
\±5 %. At 10 Hz repetition rate this would translate in a
treatment time of about 1 min.
Figure 7b shows individual filtered LAP shots super-
imposed in the middle of the phantom to achieve uniform
SOBP in an opposing irradiation scheme. The number of
filtered shots required per field depends on the tumor width
and depth, and it was found that only 1–2 filtered shots per
field would be sufficient to achieve normalized flat-top
SOBPs of up to 4 cm of width and 3–8 filtered shots per
field for wider SOBPs of 4–10 cm. An opposing irradiation
scheme in combination with the single-field-uniform-dose
scheme could be utilized for better conformity with mul-
tiple entry positions with higher order of treatment plan
complexity.
9 Discussion
We have developed a depth dose deposition model for
broad energy LAP bunches and a compact gantry design,
based on pulsed magnets as a L-IBT solution. In addition
we have shown the control scheme for filtering these
bunches and delivering uniform SOBP at the patient site
via the gantry design. One common critique of L-IBT is the
lack of dose control compared to standard accelerators.
Recently, an unprecedented relative dose uncertainty of
below 10 % has been achieved during cell-irradiation
experiments with laser-driven protons [26], which was
previously reported as 28 % [28], which demonstrates the
potential of high intensity lasers to control shot-to-shot
fluctuations. Our gantry concept allows fixing the energy
window of filtered bunches through ISESS; thus, shot-to-
shot fluctuations may only influence the flux delivered
while the spectral width for each bunch could be kept
almost constant. If we consider a fairly large error
of ±30 % per shot, following reference [51], this would
then increase the treatment time by a factor of three, which
is still below the acceptable limit of 10 min, which may
relax 10 Hz constraint on laser systems. Also, for shot-to-
shot fluctuations and to get enough particles, one has to
avoid operating at the maximum proton cutoff energy of
the exponential spectrum of the laser accelerator. Instead, it
would be desirable to have the maximum proton cutoff
energy at *300 MeV. Online dose control per bunch is
essential to monitor the shot-to-shot dose fluctuations and
Fig. 7 a Shows LAP shot depth dose profiles (blue) filtered through
ISESS with five different settings. A total of NLAP = 19 shots were
required to be superimposed to reach SOBP (red) of 5.4 cm width,
within uniformity of ±3 %. b Shows an opposing irradiation scheme
using the BEAD regime. The depth dose profile (blue), resulted from
dose profiles of individual filtered LAP shots (dashed blue),
overlapped inside the tumor region from opposing directions to
achieve a flat-top SOBP (red). Only 3 filtered LAP shots per field
were required to deliver uniform dose by SOBP of *8 cm width
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has been successfully used in experiments with LAP [23,
25, 26, 28].
Laser-driven IBT requires additional space for moni-
toring and control equipment, as does a con-IBT facility.
Therefore, the suggested dimensions of our gantry, with a
height of 1.7 m and a length of *3.0 m (Fig. 5), may
increase by 35–50 %, nevertheless, is still a considerable
reduction in size compared to conventional gantries. In
addition, the pulsed power sources itself can considerably
contribute to the overall size of the system as to the energy
budget. Here, a setup allowing for recovery of field energy
by resonant circuits would help to keep this contribution to
a minimum. With the overall size and weight reduction of a
pulsed gantry design compared to conventional gantry
designs, all these contributions would be greatly out-
weighed by the considerable amount of infrastructural
investment that might be saved.
The large energy-dependent divergence with wide
energy spectrum, typically observed in TNSA regime, has
provided a worst case scenario for designing the energy
selection system and the transport beamline. If in future,
another acceleration mechanism (as mentioned in Sect. 2)
could be established with improved beam parameters, such
as lower divergence angles and reduced energy spread, this
would lower the constraints on the beamline, such as lower
acceptance values for beamline elements, increase trans-
port efficiency and decrease particle waste. Thus, such
features would only compliment the proposed beamline
making our gantry concept compatible with any future
advancement in laser particle acceleration.
As laser-driven proton beams are produced in quasi-
neutral plasma bunches of protons, ions and electrons,
beam filtering with radiation protection must be integrated
into any L-IBT system. In our design, we have considered
these issues. Initial particle selection happens in the sole-
noid that collects the LAP bunches, which is thus oriented
perpendicular to the iso-line as seen in Fig. 5 away from
the patient. The dispersive bending magnets, SM1 and
SM2, are accompanied by the beam dumps D1 and D2,
respectively. Both beam dumps are necessary in order to
shield the secondary radiation produced via interactions of
out-filtered particles. Again, our design foresees that any
unwanted radiation does not directly face toward the
patient table. As an extra protection, any secondary radia-
tion from these beam dumps would be blocked by the
radiation protection cave walls around the patient area. The
amount of secondary radiation would depend on the input
proton spectrum along with co-moving electrons from
future laser acceleration experiments. The radiation pro-
tection and the design of particle dumps for laser acceler-
ated beams are not trivial; however, according to ref. [50] a
6 to 7 cm thick multilayer shielding material should be
enough to prevent leakage doses. For a detailed study of
radiation protection, we refer to future publications, as it
may influence the detailed geometry and size of a final
gantry design.
10 Conclusion and outlook
In this paper, we have presented a solution for IBT with
LAP bunches based on a novel concept for dose deposition
with broad energy bands—BEAD and a compact pulsed
power gantry system with integrated energy selection—
ISESS. The main advantage of our L-IBT solution com-
pared to previous approaches is that it combines high
collection efficiency and high transport efficiency with
greatly relaxed demands on the energy spread of the LAP
bunch. In fact, the L-IBT scheme presented here utilizes
the broad energy spread commonly observed in laser-dri-
ven proton acceleration as it deposits dose in SOBPs by
superimposing the dose of proton bunches with variable
energy windows. Therefore, our proposed solution works
well with standard laser-driven TNSA which is well
understood and can be controlled to a high level but is also
compatible with new laser acceleration mechanisms, such
as radiation pressure acceleration etc., which could poten-
tially deliver proton bunches with smaller energy spread
and better collimation.
While our BEAD scheme shows that L-IBT can be
competitive to con-IBT in terms of treatment time, the use
of pulsed magnets for the treatment greatly reduces the size
and weight of the gantry and in turn all related infra-
structure. Although our demands on maximum magnetic
field strength are moderate, the realization of a fully pulsed
gantry system at a continuous 10 Hz pulse rate is a chal-
lenge, both in terms of magnet design and in design of the
pulsed power system. However, the great reduction in
overall cost expected from a compact gantry design makes
the effort of developing it a worthwhile endeavor.
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